Hello Readers: Is the variant question keeping you awake at night? No need for that, writes Kate today in her piece on experts addressing the issue. In other news: The […]
Search results
Posted inThe Pandemic
UCSF Grand Rounds: Medical experts discuss risks of J&J vaccine
Medical experts on Thursday’s Grand Rounds delved into the risks posed by the Johnson & Johnson vaccine that the United States stopped distributing last week after reports of rare and dangerous blood clots in six recipients.
Posted inNewsletter
Grand Rounds, the tracker and some people to meet
Hello Readers: Once again we have Grand Rounds for you – and some good news on vaccines. In other news: The Covid Tracker People We Meet – A sidewalk artist […]
Posted inUncategorized
Grand Rounds, vaccines, rent debt, the tracker
Good evening: Sorry for the lateness but I was holding off for two stories – both of which are worthy of the wait. We have Grand Rounds, a fascinating discussion […]
Posted inFeatured
UCSF Grand Rounds: The vaccine is coming — soon
Doctors say the vaccine is on a clear path to be “in the arms of the public” by late December
Posted inEvents
UCSF Grand Rounds: The fourth surge, delta variant, boosters and more
UCSF Chair of the Department of Medicine Dr. Bob Wachter brings back three UCSF experts on Grand Rounds to discuss the pandemic’s fourth surge, the Delta variant, boosters and more.
Posted inThe Pandemic
UCSF Grand Rounds: The delta variant and Andy Slavitt’s reflections on the pandemic
Dr. George Rutherford speaks about worldwide updates and the delta variant, followed by a discussion between Dr. Bob Wachter and Andy Slavitt, President Biden’s senior covid-19 advisor.
Posted inNewsletter
Grand Rounds, a SFPD officer finds a new force, essential memories
Hello Readers: What happens when you retire from the SFPD? You pick up a new job – or a new police force, Julian writes today. In other news: Grand Rounds […]
Posted inFront Page
UCSF Grand Rounds: Vaccine Nationalism, Allocation, and Trust
Understanding the complexities of vaccine development, manufacturing, distribution and uptake in the middle of a global pandemic is a difficult task—even without a 75-minute time limit. Add to this discussion […]
Posted inThe Pandemic
UCSF Grand Rounds: Vaccine rollout, herd immunity, and the threat of emerging mutations
Dr. Bob Wachter and others discuss the threat of emerging covid-19 variants, the threshold for herd immunity, and UCSF’s vaccine rollout for Phase 1a.
Posted inFront Page
UCSF Grand Rounds: So far omicron appears contagious, but mild
Dr. Bob Wachter speaks to two experts about two new antiviral medications as well as the panic around the new Omicron variant.
Posted inFeatured
UCSF Grand Rounds: Two experts discuss vaccines and the state of the pandemic
Dr. Bob Wachter sits down with two experts to discuss vaccines, the current state of the pandemic and the “darkish clouds on the horizon” in Grand Rounds.
Posted inFeatured
UCSF Grand Rounds: A Conversation with Ashish Jha, the Covid-19 Cronkite
Dr. Bob Wachter conversed with Dr. Ashish Jha on Thursday’s Grand Rounds, tackling boosters, mandates, the Biden administration and more.
Posted inThe Pandemic
UCSF Grand Rounds: Exploring the coronavirus’ evolutionary biology and the future of rapid testing
Dr. Bob Wachter asks leading experts two big questions for UCSF’s Grand Rounds: is the delta variant as bad as it gets, and what is the role of rapid testing in determining the future of the pandemic?
Posted inEvents
UCSF Grand Rounds: The Delta variant and vaccine efficacy, durability and boosters
In this special edition of Grand Rounds, Dr. Bob Wachter speaks with Dr. Shane Crotty and Dr. Carlos Del Rio about the current outbreak and the delta variant, as well as vaccine efficacy, durability and boosters.
